Tekla Life Sciences Investors
(NYSE : HQL)

( )
HQL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Miscellaneous » Investment Trusts Or Mutual Funds
symbolcompany%chnglast%shortavg$volume
HYG -0.02%84.600.0%$2298.74m
MSPMadison Strategic Sector Premium Fund 0.44%27.270.0%$414.28m
MBB 0.00%110.220.0%$221.94m
XLC 0.02%61.140.0%$172.88m
MUB -0.01%115.150.0%$137.99m
XLRE 0.00%35.650.0%$135.30m
HYLB -0.04%48.520.0%$126.32m
ESGU 0.00%78.210.0%$116.61m
SPLG 0.03%40.270.0%$109.94m
IGSB 0.00%54.920.0%$109.84m
IGIB 0.00%60.810.0%$107.43m
ESGE 0.00%37.310.0%$64.19m
FIXD 0.00%54.900.0%$53.82m
SPDW 0.03%29.740.0%$52.24m
VTEB -0.04%54.100.0%$52.10m

Company Profile

Tekla Life Sciences Investors is a non-diversified closed-end healthcare fund, which engages in investing in the life sciences industry. The fund primarily invest in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, and healthcare information technology and services. The company was founded on May 8, 1992 and is headquartered in Boston, MA.